Humoral Immunity Study After Booster Vaccination of Soberana Plus (Republic of Cuba) Against COVID-19

Condition:   Humoral Immunity Intervention:   Biological: Conjugate vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. Sponsor:   Gomel State Medical University Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials